Anakinra for the Prevention of Cytokine Release Syndrome and Neurotoxicity in Patients With B-Cell Non-Hodgkin Lymphoma Receiving CD19-Targeted CAR-T Cell Therapy
PHASE2
This phase II trial studies how well anakinra works in decreasing the occur...
Status
Completed
Location
Fred Hutch/University of Washington Cancer Consortium
Pralatrexate With Bendamustine and Total-Body Irradiation Followed by Donor Stem Cell Transplant for the Treatment of Relapsed or Refractory T-Cell Non-Hodgkin Lymphoma
PHASE1
This phase I/II trial studies the side effects and best dose of pralatrexat...
Status
Recruiting
Location
Fred Hutch/University of Washington Cancer Consortium
Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia
PHASE2
This phase II trial tests the addition of venetoclax and/or blinatumomab to...
Allogeneic CMV-Specific CD19-CAR T Cells Plus CMV-MVA Triplex Vaccine After Matched Related Donor Hematopoietic Cell Transplant for the Treatment of Patients With High-Risk Acute Lymphoblastic Leukemia
EARLY_PHASE1
This early phase I trial tests the safety and side effects of allogeneic CM...